S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CYTK Cytokinetics Inc

49.69

0.50 (1.02%)

Pre Market

Last Updated: 00:09:04

Delayed by 15 minutes

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Cytokinetics (NASDAQ:CYTK)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Cytokinetics Charts.

Cytokinetics (NASDAQ:CYTK)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Cytokinetics Charts.

Cytokinetics Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (16 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (16 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (16 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (16 hours ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 7 January 2025 (16 hours ago) • Edgar (US Regulatory)

Cytokinetics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tuesday 7 January 2025 (17 hours ago) • GlobeNewswire Inc.

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Saturday 4 January 2025 (4 days ago) • GlobeNewswire Inc.

Cytokinetics Announces European Medicines Agency Validation of Marketing Authorization Application for Aficamten for the Treatment of Obstructive Hypertrophic Cardiomyopathy
Monday 23 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Cytokinetics Announces Sanofi Acquired Rights to Develop and Commercialize Aficamten in Greater China
Friday 20 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 17 December 2024 (3 weeks ago) • Edgar (US Regulatory)

More Cytokinetics Inc News Articles

Woodside Petroleum

Australian SE All Ordina...

Commonwealth Bank Of Aus...

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions